Breyanzi genetically modified autologous T cells Images
Generic Name: lisocabtagene maraleucel
This medication has been identified as Breyanzi genetically modified autologous T cells. It is supplied by Bristol-Myers Squibb Company.
Breyanzi is used in the treatment of Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; B-Cell Lymphoma; Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma and belongs to the drug class miscellaneous antineoplastics. Breyanzi genetically modified autologous T cells is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Breyanzi
- Generic Name
- lisocabtagene maraleucel
- Strength
- genetically modified autologous T cells
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
- National Drug Code (NDC)
- 73153-0900
See also:
Rituxan
Rituxan is used to treat certain leukemias and lymphomas and some non-cancer conditions, such as ...
Monjuvi
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL) in combination with lenalidomide ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Kymriah
Kymriah is used to treat B-cell precursor acute lymphoblastic leukemia (ALL), large B-cell ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma (FL) in adults. It is a p ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Tazverik
Tazverik (tazemetostat) used for the treatment of patients with epithelioid sarcoma and follicular ...
More about Breyanzi (lisocabtagene maraleucel)
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.